Logo

Kalypsys to Provide Screening Technology to NIH Chemical Genomics Center; Deal Worth Up to $30M

Jun 09, 2004

NEW YORK, June 9 (GenomeWeb News) - The National Institutes of Health will use screening technology from Kalypsys at its newly created NIH Chemical Genomics Center, the company said today.

 

The agreement is worth up to $30 million, according to San Diego-based Kalypsys. The Chemical Genomics Center, based at the National Human Genome Research Institute, will use Kalypsys' high throughput screening technology to produce chemical tools to help understand the function of the genome.

 

The NIH Chemical Genomics Center is the first of up to ten pilot centers established by the Molecular Libraries and Imaging Initiative, led by the National Institute of Mental Health. NIH plans to establish a repository for up to one million chemical compounds. Data generated by the chemical genomics network will be deposited in a freely available central database, called PubChem.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.